Virtual Medicinal Product (VMP) - Azelastine 210micrograms/dose nasal spray
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Azelastine 210micrograms/dose nasal spray | Start Date 01-07-2023 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- actuation
- Unit Dose UOM
- actuation
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Nasal
- Form
- Spray
- Ontology Form/Route
- solutionspray.nasal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- R01AC03
- BNF Codes
-
- BNF code 12020100
| Code | Start Date | End Date |
|---|---|---|
| 42029711000001100 | 01-07-2023 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Azelastine hydrochloride | Based on Ingredient Substance | 210 microgram | 1 actuation |
Name
Azelastine hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
210
Strength and UOM (Dmr)
1
Parent Products
-
VTMAzelastine
-
VMP(Current) Azelastine 210micrograms/dose nasal ...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 20 ml | 990 | Part VIIIA Category C |